Faroogh Marofi

Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial

Sanam Dolati, Leili Aghebati‐Maleki, Majid Ahmadi et al. · Journal of Cellular Physiology · 2017 · 100 citations

Nanocurcumin Therapy, Nanotherapeutics, Engineering +21

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

Sanam Dolati, Majid Ahmadi, Leili Aghebti-Maleki et al. · Pharmacological Reports · 2018 · 95 citations

Nanoparticles, Nanomedicine, Inflammation +12

T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure

Mahnaz Ghaebi, Samaneh Abdolmohammadi‐Vahid, Majid Ahmadi et al. · Journal of Reproductive Immunology · 2018 · 68 citations

T Cell Subsets, Cell Therapy, Bone Marrow Failure +10

miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4

Mohammad Reza Mohammad Hoseini Azar, Hamed Aghazadeh, Halgurd Nadhim Mohammed et al. · International Immunopharmacology · 2021 · 47 citations

Oncology, Medicine, Oxaliplatin Chemoresistance +9

Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019

Mina Mohammadhosayni, Fatemeh Mohammadi, Fatemeh Ezzatifar et al. · International Immunopharmacology · 2021 · 46 citations · Full text

Coronavirus Disease 2019, Viral Diagnostics, Neurovirology +7